Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Giuliano Bonfanti"'
Autor:
Luca Sorrentino, Marco Vitellaro, Giuliano Bonfanti, Marcello Guaglio, Filiberto Belli, Luigi Battaglia, Alessandro Cesa Bianchi, Massimo Milione
Publikováno v:
International Journal of Colorectal Disease. 34:2161-2169
Benefits of neoadjuvant chemo-radiotherapy (CRT) are well known for locally advanced and/or node-positive rectal cancer, but the best timing for CRT has been less explored for cT3N0 patients. The aim of the present study was to compare the 5-year dis
Autor:
Marta Barisella, Stefano Signoroni, Giuliano Bonfanti, Andrea Mancini, Marco Vitellaro, Paola Sala, Lucio Bertario, Elia Poiasina
Publikováno v:
Surgical Endoscopy. 25:1866-1875
Familial adenomatous polyposis (FAP) is a dominantly inherited syndrome. Risk of cancer begins to increase after age 20 years if not treated. The purpose of this study was to evaluate the feasibility and short- and long-term outcomes after laparoscop
Autor:
Caroline Bruce, Salvatore Andreola, Ermanno Leo, Alberto Vannelli, Marco Vitellaro, Luigi Battaglia, Filiberto Belli, Gianfrancesco Gallino, Giuliano Bonfanti
Publikováno v:
Surgical Oncology. 13:103-109
The treatment of tumors of the distal rectum continues to be a matter of great controversy among oncologic surgeons. There are increasingly promising indications that functionally conservative surgery may be a valid therapeutic alternative to convent
Autor:
Gian Francesco Gallino, Filiberto Belli, Francesca Valvo, Giuliano Bonfanti, Salvatore Andreola, Grazia Sirizzotti, Ermanno Leo, Paolo Greco, Gorana Tomasic
Publikováno v:
Annals of Surgical Oncology. 8:611-615
Recent reports suggest that a distal clearance (DC) of 10 mm at the lower surgical margin may be considered adequate in the surgical treatment of rectal cancer, but there are no data on the possible adequacy of a10-mm DC in N0 patients in whom a good
Autor:
Gianfrancesco Gallino, Guido Cozzi, Roberto Gallo, Filiberto Belli, Giuliano Bonfanti, Salvatore Andreola, Lucio Bertario, Elia Biganzoli, Ermanno Leo, Monica Salvetti, Luigi Mariani, Enrico Civelli
Publikováno v:
Scopus-Elsevier
Purpose In modern management of rectal carcinoma, the preoperative evaluation of disease parameters is important for selection of therapeutic options. Such parameters are currently defined through endorectal ultrasonography or endoscopic ultrasonogra
Autor:
Enrico Civelli, Francesca Valvo, Grazia Sirizzotti, Giuliano Bonfanti, Ermanno Leo, Salvatore Andreola, Mary Gios, Filiberto Belli, F. Ferro, Elisabetta Zingaro, Cinzia Brunelli, Gianfrancesco Gallino
Publikováno v:
Scopus-Elsevier
Background: At present, abdominoperineal resection remains the most diffuse method of treatment of very low rectal cancer. Today, we can avoid this method in some patients by using a sphincter-saving procedure. Methods: From March 1990 to January 199
Autor:
Luigi Mariani, Sabrina Piacenza, Cecilia Gavazzi, Federico Bozzetti, Giuliano Bonfanti, Luca Cozzaglio, Rosalba Miceli, Nicoletta Rossi
Publikováno v:
Scopus-Elsevier
Background: Clinical trials investigating the potential benefits of perioperative total parenteral nutrition (TPN) for reducing the risk of surgery in malnourished cancer patients have yielded controversial results. Methods: Ninety elective surgical
Autor:
Rosalba Miceli, Ettore Marubini, Federico Bozzetti, Giuliano Bonfanti, Chiara Piano, Leandro Gennari, Nadia Crose
Publikováno v:
Annals of Surgery. 226:613-620
OBJECTIVE: The purpose of this study was to analyze postoperative morbidity and mortality of patients included in a randomized trial comparing total versus subtotal gastrectomy for gastric cancer. SUMMARY BACKGROUND DATA: There is controversy as to w
Autor:
Giuliano Bonfanti, Maria Bochicchio, Filippo de Braud, Maria Di Bartolomeo, Roberto Doci, Vittorio Gebbia, Federico Bozzetti, Emilio Bajetta, Luca Cozzaglio
Publikováno v:
Oncology. 52:41-44
Many patients with advanced gastric cancer cannot be treated with intensive chemotherapy. In an attempt to provide a feasible regimen for such patients, the combination of etoposide, leucovorin and fluorouracil (ELF) has been developed with promising
Autor:
A. Maria Bochicchio, Cesare Bartoli, Giuliano Bonfanti, Roberto Buzzoni, Franco Nolè, Marco Colleoni, Emilio Bajetta, Riccardo A. Audisio
Publikováno v:
Cancer. 72:3196-3201
BACKGROUND Chemoimmunotherapy is being evaluated in the most common gastrointestinal tumors, but little data are available on hepatocellular carcinoma (HCC). Considering the encouraging objective response rates and the absence of important side effec